2013
DOI: 10.1371/journal.pone.0083519
|View full text |Cite
|
Sign up to set email alerts
|

Induction of Paclitaxel Resistance by ERα Mediated Prohibitin Mitochondrial-Nuclear Shuttling

Abstract: Paclitaxel is a drug within one of the most promising classes of anticancer agents. Unfortunately, clinical success of this drug has been limited by the insurgence of cellular resistance. To address this, Paclitaxel resistance was modeled in an in vitro system using estrogen treated prostate cancer cells. This study demonstrates that emerging resistance to clinically relevant doses of Paclitaxel is associated with 17-β-estradiol (E2) treatment in PC-3 cells, but not in LNCaP cells. We found that small interfer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(23 citation statements)
references
References 35 publications
0
23
0
Order By: Relevance
“…However, a similar effect of PHB manipulation in adipocytes in vitro and in vivo (4,(8)(9)(10) suggests that the phenotype we have observed is most likely due to the role of PHB in adipocytes. PHB translocates from mitochondria to the nucleus in response to estrogen (17). In addition, PHB has been associated with the function of Tfam and nuclear factorlike 2 (Nrf-2) (18,19).…”
Section: Discussionmentioning
confidence: 99%
“…However, a similar effect of PHB manipulation in adipocytes in vitro and in vivo (4,(8)(9)(10) suggests that the phenotype we have observed is most likely due to the role of PHB in adipocytes. PHB translocates from mitochondria to the nucleus in response to estrogen (17). In addition, PHB has been associated with the function of Tfam and nuclear factorlike 2 (Nrf-2) (18,19).…”
Section: Discussionmentioning
confidence: 99%
“…2 ). In androgen-independent prostate cancer cells, estrogen activates ERα and promotes mitochondrial-nuclear PHB1 translocation, leading to cancer cell resistance to paclitaxel [ 52 ]. However, the translocation of PHB1 from the cytoplasm to the nucleus is also closely related to other apoptotic events.…”
Section: Phb and Nuclear Trafficking And Apoptosismentioning
confidence: 99%
“… 14 , 15 These findings are in striking contrast to the previously proposed antiproliferative role of PHB and the predicted function as a negative regulator of E2F-mediated transcription, 10 , 11 though the difference in localization of PHB may explain the discrepancy. PHB has been visualized in the mitochondria, 16 , 17 nucleus 11 , 18 , 19 and plasma membrane 20 , 21 in different mammalian cell lines, although the exact role of PHB in each location remains unclear.…”
mentioning
confidence: 99%